Latest Ratios: P/E Ratio 37.5x · EV/EBITDA 21.6x · ROE 11.9%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.0B | $4.0B | $3.0B | $2.8B | $3.1B | $4.2B | $3.1B | $2.8B | $2.4B | $3.2B | $3.5B |
| Enterprise Value | $5.8B | $4.7B | $3.6B | $3.4B | $3.7B | $4.7B | $3.6B | $3.4B | $3.1B | $3.8B | $4.1B |
| P/E Ratio → | 37.52 | 29.73 | 24.24 | 29.86 | 21.83 | 35.61 | 28.48 | 34.07 | 15.09 | 36.03 | 27.87 |
| P/S Ratio | 3.13 | 2.48 | 1.94 | 1.91 | 2.14 | 3.06 | 2.35 | 2.11 | 1.71 | 2.36 | 2.55 |
| P/B Ratio | 4.23 | 3.35 | 2.85 | 2.65 | 3.08 | 4.51 | 3.34 | 3.17 | 2.76 | 3.78 | 4.22 |
| P/FCF | 131.37 | 104.17 | 30.85 | 34.07 | — | 50.08 | 18.75 | 20.24 | 72.41 | 25.94 | 24.94 |
| P/OCF | 39.48 | 31.31 | 19.22 | 16.43 | 255.03 | 29.12 | 14.28 | 15.78 | 28.42 | 17.84 | 15.84 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.94 | 2.33 | 2.35 | 2.58 | 3.42 | 2.72 | 2.56 | 2.20 | 2.80 | 2.97 |
| EV / EBITDA | 21.58 | 17.69 | 14.40 | 16.06 | 14.88 | 21.21 | 16.73 | 15.14 | 11.94 | 14.43 | 15.79 |
| EV / EBIT | 27.95 | 22.90 | 18.94 | 22.05 | 18.85 | 27.73 | 23.76 | 28.02 | 15.09 | 22.74 | 22.10 |
| EV / FCF | — | 123.48 | 37.04 | 41.76 | — | 55.83 | 21.76 | 24.57 | 93.08 | 30.73 | 29.03 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.5% | 33.5% | 32.6% | 31.6% | 34.0% | 32.9% | 31.9% | 32.2% | 33.5% | 35.1% | 34.5% |
| Operating Margin | 12.8% | 12.8% | 12.3% | 10.6% | 13.7% | 12.3% | 12.6% | 12.8% | 14.6% | 15.9% | 15.4% |
| Net Profit Margin | 8.3% | 8.3% | 8.0% | 6.4% | 9.8% | 8.6% | 8.2% | 6.2% | 11.3% | 6.6% | 9.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.9% | 11.9% | 11.8% | 9.1% | 14.5% | 12.7% | 12.1% | 9.4% | 18.4% | 10.6% | 15.0% |
| ROA | 6.3% | 6.3% | 6.2% | 4.7% | 7.6% | 6.8% | 6.3% | 4.6% | 8.9% | 5.3% | 7.5% |
| ROIC | 8.6% | 8.6% | 8.6% | 7.0% | 9.7% | 8.9% | 8.6% | 8.4% | 10.2% | 11.3% | 11.1% |
| ROCE | 11.1% | 11.1% | 10.9% | 8.9% | 12.2% | 11.2% | 10.9% | 10.7% | 13.0% | 14.6% | 14.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.65 | 0.65 | 0.60 | 0.63 | 0.65 | 0.55 | 0.56 | 0.70 | 0.83 | 0.73 | 0.72 |
| Debt / EBITDA | 2.90 | 2.90 | 2.51 | 3.09 | 2.61 | 2.30 | 2.43 | 2.76 | 2.78 | 2.36 | 2.32 |
| Net Debt / Equity | — | 0.62 | 0.57 | 0.60 | 0.63 | 0.52 | 0.54 | 0.68 | 0.79 | 0.70 | 0.69 |
| Net Debt / EBITDA | 2.77 | 2.77 | 2.41 | 2.96 | 2.53 | 2.19 | 2.32 | 2.67 | 2.65 | 2.25 | 2.22 |
| Debt / FCF | — | 19.32 | 6.20 | 7.69 | — | 5.75 | 3.02 | 4.33 | 20.67 | 4.79 | 4.09 |
| Interest Coverage | 7.00 | 7.00 | 6.66 | 6.16 | 13.53 | 13.55 | 10.31 | 6.02 | 9.25 | 8.66 | 10.13 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.10 | 4.10 | 3.55 | 3.96 | 3.43 | 3.19 | 3.43 | 3.91 | 3.83 | 3.39 | 3.36 |
| Quick Ratio | 1.53 | 1.53 | 1.34 | 1.43 | 1.36 | 1.42 | 1.67 | 1.82 | 1.55 | 1.25 | 1.46 |
| Cash Ratio | 0.14 | 0.14 | 0.10 | 0.12 | 0.08 | 0.11 | 0.11 | 0.11 | 0.15 | 0.14 | 0.12 |
| Asset Turnover | — | 0.72 | 0.77 | 0.72 | 0.73 | 0.79 | 0.77 | 0.76 | 0.76 | 0.79 | 0.83 |
| Inventory Turnover | 1.58 | 1.58 | 1.75 | 1.66 | 1.68 | 2.25 | 2.38 | 2.12 | 1.88 | 1.91 | 2.24 |
| Days Sales Outstanding | — | 69.14 | 67.99 | 68.21 | 76.73 | 69.05 | 64.16 | 58.82 | 67.21 | 52.37 | 51.33 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.4% | 1.7% | 2.3% | 2.5% | 2.2% | 1.6% | 2.1% | 2.2% | 2.4% | 1.7% | 1.4% |
| Payout Ratio | 51.8% | 51.8% | 55.5% | 74.1% | 48.9% | 56.2% | 60.3% | 75.8% | 36.5% | 60.3% | 39.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.7% | 3.4% | 4.1% | 3.3% | 4.6% | 2.8% | 3.5% | 2.9% | 6.6% | 2.8% | 3.6% |
| FCF Yield | 0.8% | 1.0% | 3.2% | 2.9% | — | 2.0% | 5.3% | 4.9% | 1.4% | 3.9% | 4.0% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 3.2% | 2.7% | 1.4% |
| Total Shareholder Yield | 1.4% | 1.7% | 2.3% | 2.5% | 2.2% | 2.6% | 2.1% | 2.2% | 5.7% | 4.4% | 2.8% |
| Shares Outstanding | — | $43M | $42M | $42M | $42M | $42M | $42M | $42M | $42M | $44M | $45M |
Raw material cost volatility
According to current market data, Sensient trades at a trailing P/E of 38.03, which appears elevated relative to its historical averages and suggests that investors are pricing in a premium for the company's defensive, ingredient-focused business model despite its modest overall revenue growth profile.
The forward P/E of 30.60 implies that the market anticipates sustained earnings expansion, yet the PEG ratio of 9.37 indicates that this valuation is quite rich relative to near-term growth expectations. Investors should monitor whether the company's specialized natural ingredient portfolio can justify these multiples compared to broader specialty chemical peers that often trade at lower earnings multiples.
Based on reported financial statements, Sensient’s ROIC has hovered in the low single digits, reaching 2.6% in 2026Q1, which indicates that the firm is currently struggling to generate returns on invested capital that meaningfully exceed its likely cost of capital in the current interest rate environment.
The persistent gap between ROIC and historical benchmarks suggests that the company's asset-heavy manufacturing footprint may be weighing on capital efficiency. Unless management can drive higher margin expansion through its natural ingredient transition, the company may continue to face challenges in compounding shareholder value effectively over the long term.
As reported in recent filings, the company's cash conversion cycle remains extended at 243 days in 2026Q1, primarily driven by high inventory days of 216, which suggests that Sensient carries significant capital tied up in agricultural raw materials and finished goods relative to its peers.
This high inventory dependence reflects the nature of sourcing specialized natural extracts, but it creates a structural drag on free cash flow generation. Investors should watch for improvements in SKU rationalization, as reducing this cycle is essential for the company to improve its operational cash flow conversion and overall liquidity profile.
The P/E ratio is frequently misapplied to Sensient because it obscures the significant non-cash charges and working capital volatility inherent in its agricultural-based manufacturing model, which often leads to an inaccurate assessment of the company's true underlying earnings power and cash-generating capability.
Analysts should instead focus on EV/EBITDA or P/FCF, as these metrics better account for the company's capital structure and the lumpy nature of its cash flows. Relying solely on P/E risks misinterpreting the firm's valuation by failing to adjust for the cyclicality of raw material costs and the associated inventory-related cash flow swings.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SXT stock.
Sensient Technologies Corporation's current P/E ratio is 37.5x. The historical average is 21.1x. This places it at the 97th percentile of its historical range.
Sensient Technologies Corporation's current EV/EBITDA is 21.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.5x.
Sensient Technologies Corporation's return on equity (ROE) is 11.9%. The historical average is 12.6%.
Based on historical data, Sensient Technologies Corporation is trading at a P/E of 37.5x. This is at the 97th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Sensient Technologies Corporation's current dividend yield is 1.38% with a payout ratio of 51.8%.
Sensient Technologies Corporation has 33.5% gross margin and 12.8% operating margin. Operating margin between 10-20% is typical for established companies.
Sensient Technologies Corporation's Debt/EBITDA ratio is 2.9x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.